Literature DB >> 30970357

Post-Stroke Blood-Brain Barrier Disruption and Poor Functional Outcome in Patients Receiving Thrombolytic Therapy.

Zurab Nadareishvili1, Alexis N Simpkins1, Emi Hitomi1, Dennys Reyes1, Richard Leigh2.   

Abstract

BACKGROUND AND
PURPOSE: The role played by post-stroke inflammation after an ischemic event in limiting functional recovery remains unclear. One component of post-stroke inflammation is disruption of the blood-brain barrier (BBB). This study examines the relationship between post-stroke BBB disruption and functional outcome.
METHODS: Acute stroke patients treated with thrombolysis underwent magnetic resonance imaging scanning 24 h and 5 days after their initial event. BBB permeability maps were generated from perfusion weighted imaging. Average permeability was calculated in the affected hemisphere. Good functional outcome, defined as a modified Rankin score of 0 or 1, was compared with average permeability using logistic regression.
RESULTS: Of the 131 patients enrolled, 76 patients had the necessary data to perform the analysis at 24 h, and 58 -patients had data for the 5-day assessment. Higher BBB permeability measured at 24 h (OR 0.57; 95% CI 0.33-0.99, p = 0.045) and at 5 days (OR 0.24; 95% CI 0.09-0.66, p = 0.005) was associated with worse functional outcome 1-3 months after the acute ischemic stroke. For every percentage increase in BBB disruption at 5 days, there was a 76% decrease in the chance of achieving a good functional outcome after stroke. Multivariate analysis found this to be independent of age, stroke volume, or clinical stroke severity.
CONCLUSIONS: Post-stroke BBB disruption appears to be predictive of functional outcome irrespective of stroke size.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Blood-brain barrier; Functional outcome; Ischemic stroke; Magnetic resonance imaging; Post-stroke inflammation

Mesh:

Substances:

Year:  2019        PMID: 30970357      PMCID: PMC6610790          DOI: 10.1159/000499666

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  30 in total

Review 1.  MRI-guided selection of patients for treatment of acute ischemic stroke.

Authors:  Richard Leigh; John W Krakauer
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

2.  Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

Authors:  Susan C Fagan; Jennifer L Waller; Fenwick T Nichols; David J Edwards; L Creed Pettigrew; Wayne M Clark; Christiana E Hall; Jeffrey A Switzer; Adviye Ergul; David C Hess
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

3.  Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.

Authors:  Jacob Elkins; Roland Veltkamp; Joan Montaner; S Claiborne Johnston; Aneesh B Singhal; Kyra Becker; Maarten G Lansberg; Weihua Tang; Ih Chang; Kumar Muralidharan; Sarah Gheuens; Lahar Mehta; Mitchell S V Elkind
Journal:  Lancet Neurol       Date:  2017-02-15       Impact factor: 44.182

4.  Human cerebral infarct: a proposed histopathologic classification based on 137 cases.

Authors:  Hernando Mena; Diego Cadavid; Elisabeth J Rushing
Journal:  Acta Neuropathol       Date:  2004-10-26       Impact factor: 17.088

5.  Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.

Authors:  Alexis N Simpkins; Christian Dias; Richard Leigh
Journal:  Stroke       Date:  2016-07-26       Impact factor: 7.914

6.  Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

Authors:  Mathias Gelderblom; Frank Leypoldt; Karin Steinbach; Doerthe Behrens; Chi-Un Choe; Dominic A Siler; Thiruma V Arumugam; Ellen Orthey; Christian Gerloff; Eva Tolosa; Tim Magnus
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

7.  Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

Authors:  Y Lampl; M Boaz; R Gilad; M Lorberboym; R Dabby; A Rapoport; M Anca-Hershkowitz; M Sadeh
Journal:  Neurology       Date:  2007-10-02       Impact factor: 9.910

8.  What is immune privilege (not)?

Authors:  Ian Galea; Ingo Bechmann; V Hugh Perry
Journal:  Trends Immunol       Date:  2006-11-28       Impact factor: 16.687

9.  A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.

Authors:  H C A Emsley; C J Smith; R F Georgiou; A Vail; S J Hopkins; N J Rothwell; P J Tyrrell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

10.  Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients.

Authors:  Richard Leigh; Shyian S Jen; Daniel D Varma; Argye E Hillis; Peter B Barker
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more
  13 in total

1.  CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke.

Authors:  Mustafa Balkaya; Il-Doo Kim; Faariah Shakil; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-13       Impact factor: 6.200

Review 2.  Imaging After Thrombolysis and Thrombectomy: Rationale, Modalities and Management Implications.

Authors:  Felix C Ng; Bruce C V Campbell
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-06       Impact factor: 5.081

3.  High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats.

Authors:  Junzhi Yang; Robert D Betterton; Erica I Williams; Joshua A Stanton; Elizabeth S Reddell; Chidinma E Ogbonnaya; Emma Dorn; Thomas P Davis; Jeffrey J Lochhead; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

Review 4.  Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.

Authors:  Eduardo Candelario-Jalil; Rick M Dijkhuizen; Tim Magnus
Journal:  Stroke       Date:  2022-04-07       Impact factor: 10.170

5.  Characterization of the Blood Brain Barrier Disruption in the Photothrombotic Stroke Model.

Authors:  Rebecca Z Weber; Lisa Grönnert; Geertje Mulders; Michael A Maurer; Christian Tackenberg; Martin E Schwab; Ruslan Rust
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.566

6.  Blood-Brain Barrier Disruption and Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis.

Authors:  Francesco Arba; Chiara Rinaldi; Danilo Caimano; Federica Vit; Giorgio Busto; Enrico Fainardi
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

7.  Association of cerebral microvascular perfusion and diffusion dynamics detected by intravoxel incoherent motion-diffusion weighted imaging with initial neurological function and clinical outcome in acute ischemic stroke.

Authors:  Fei Chen; Zhenyu Dai; Lizheng Yao; Congsong Dong; Haicun Shi; Weiqiang Dou; Wei Xing
Journal:  PeerJ       Date:  2021-09-16       Impact factor: 2.984

Review 8.  Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke.

Authors:  Courtney Davis; Sean I Savitz; Nikunj Satani
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

9.  Combined Perfusion and Permeability Imaging Reveals Different Pathophysiologic Tissue Responses After Successful Thrombectomy.

Authors:  Arne Potreck; Matthias A Mutke; Charlotte S Weyland; Johannes A R Pfaff; Peter A Ringleb; Sibu Mundiyanapurath; Markus A Möhlenbruch; Sabine Heiland; Mirko Pham; Martin Bendszus; Angelika Hoffmann
Journal:  Transl Stroke Res       Date:  2021-01-11       Impact factor: 6.829

Review 10.  Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy.

Authors:  Aneesha Achar; Rosemary Myers; Chaitali Ghosh
Journal:  Biomedicines       Date:  2021-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.